Works matching IS 00070920 AND DT 2015 AND VI 112 AND IP 2

Results: 25

New insights into signalling-pathway alterations in rhabdomyosarcoma.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 227, doi. 10.1038/bjc.2014.471

By:

Zhu, B;
Davie, J K

Publication type:

Article

Imaging tumour hypoxia with positron emission tomography.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 238, doi. 10.1038/bjc.2014.610

By:

Fleming, I N;
Manavaki, R;
Blower, P J;
West, C;
Williams, K J;
Harris, A L;
Domarkas, J;
Lord, S;
Baldry, C;
Gilbert, F J

Publication type:

Article

Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 375, doi. 10.1038/bjc.2014.605

By:

Otero-Estévez, O;
De Chiara, L;
Rodríguez-Berrocal, F J;
de la Cadena, M Páez;
Cubiella, J;
Castro, I;
Gonzalez-Mao, C;
Hernandez, V;
Martínez-Zorzano, V S

Publication type:

Article

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 290, doi. 10.1038/bjc.2014.557

By:

Defferrari, R;
Mazzocco, K;
Ambros, I M;
Ambros, P F;
Bedwell, C;
Beiske, K;
Bénard, J;
Berbegall, A P;
Bown, N;
Combaret, V;
Couturier, J;
Erminio, G;
Gambini, C;
Garaventa, A;
Gross, N;
Haupt, R;
Kohler, J;
Jeison, M;
Lunec, J;
Marques, B

Publication type:

Article

Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 345, doi. 10.1038/bjc.2014.595

By:

Horimoto, Y;
Arakawa, A;
Harada-Shoji, N;
Sonoue, H;
Yoshida, Y;
Himuro, T;
Igari, F;
Tokuda, E;
Mamat, O;
Tanabe, M;
Hino, O;
Saito, M

Publication type:

Article

The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 319, doi. 10.1038/bjc.2014.572

By:

Ward, S T;
Li, K K;
Hepburn, E;
Weston, C J;
Curbishley, S M;
Reynolds, G M;
Hejmadi, R K;
Bicknell, R;
Eksteen, B;
Ismail, T;
Rot, A;
Adams, D H

Publication type:

Article

Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 329, doi. 10.1038/bjc.2014.589

By:

Hennig, D;
Müller, S;
Wichmann, C;
Drube, S;
Pietschmann, K;
Pelzl, L;
Grez, M;
Bug, G;
Heinzel, T;
Krämer, O H

Publication type:

Article

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 251, doi. 10.1038/bjc.2014.639

By:

Collins, G S;
Reitsma, J B;
Altman, D G;
Moons, K G M

Publication type:

Article

QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 296, doi. 10.1038/bjc.2014.564

By:

Ghatalia, P;
Je, Y;
Kaymakcalan, M D;
Sonpavde, G;
Choueiri, T K

Publication type:

Article

Monitoring gastric cancer progression with circulating tumour DNA.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 352, doi. 10.1038/bjc.2014.609

By:

Hamakawa, T;
Kukita, Y;
Kurokawa, Y;
Miyazaki, Y;
Takahashi, T;
Yamasaki, M;
Miyata, H;
Nakajima, K;
Taniguchi, K;
Takiguchi, S;
Mori, M;
Doki, Y;
Kato, K

Publication type:

Article

PARVB overexpression increases cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 338, doi. 10.1038/bjc.2014.590

By:

Eslami, A;
Miyaguchi, K;
Mogushi, K;
Watanabe, H;
Okada, N;
Shibuya, H;
Mizushima, H;
Miura, M;
Tanaka, H

Publication type:

Article

Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 266, doi. 10.1038/bjc.2014.607

By:

Zhang, D S;
Jin, Y;
Luo, H Y;
Wang, Z Q;
Qiu, M Z;
Wang, F H;
Li, Y H;
Xu, R H

Publication type:

Article

Symptom lead times in lung and colorectal cancers: what are the benefits of symptom-based approaches to early diagnosis?

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 271, doi. 10.1038/bjc.2014.597

By:

Biswas, M;
Ades, A E;
Hamilton, W

Publication type:

Article

The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 382, doi. 10.1038/bjc.2014.604

By:

Ragnum, H B;
Vlatkovic, L;
Lie, A K;
Axcrona, K;
Julin, C H;
Frikstad, K M;
Hole, K H;
Seierstad, T;
Lyng, H

Publication type:

Article

Beyond BRAF: where next for melanoma therapy?

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 217, doi. 10.1038/bjc.2014.476

By:

Fedorenko, I V;
Gibney, G T;
Sondak, V K;
Smalley, K S M

Publication type:

Article

Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 306, doi. 10.1038/bjc.2014.602

By:

Ansaloni, L;
Coccolini, F;
Morosi, L;
Ballerini, A;
Ceresoli, M;
Grosso, G;
Bertoli, P;
Busci, L M;
Lotti, M;
Cambria, F;
Pisano, M;
Rossetti, D;
Frigerio, L;
D'Incalci, M;
Zucchetti, M

Publication type:

Article

Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 283, doi. 10.1038/bjc.2014.592

By:

Rakha, E A;
Tan, P H;
Varga, Z;
Tse, G M;
Shaaban, A M;
Climent, F;
van Deurzen, C H M;
Purnell, D;
Dodwell, D;
Chan, T;
Ellis, I O

Publication type:

Article

BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 391, doi. 10.1038/bjc.2014.603

By:

Kuo, P-C;
Huang, C-W;
Lee, C-I;
Chang, H-W;
Hsieh, S-W;
Chung, Y-P;
Lee, M-S;
Huang, C-S;
Tsao, L-P;
Tsao, Y-P;
Chen, S-L

Publication type:

Article

Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 357, doi. 10.1038/bjc.2014.543

By:

Komatsu, S;
Ichikawa, D;
Hirajima, S;
Nagata, H;
Nishimura, Y;
Kawaguchi, T;
Miyamae, M;
Okajima, W;
Ohashi, T;
Konishi, H;
Shiozaki, A;
Fujiwara, H;
Okamoto, K;
Tsuda, H;
Imoto, I;
Inazawa, J;
Otsuji, E

Publication type:

Article

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 260, doi. 10.1038/bjc.2014.591

By:

Choi, Y J;
Lee, S H;
Lee, J-L;
Ahn, J-H;
Lee, K-H;
You, D;
Hong, B;
Hong, J H;
Ahn, H

Publication type:

Article

IRAK signalling in cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 232, doi. 10.1038/bjc.2014.513

By:

Rhyasen, G W;
Starczynowski, D T

Publication type:

Article

B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 403, doi. 10.1038/bjc.2014.545

By:

Inoue, A;
Okamoto, K;
Fujino, Y;
Nakagawa, T;
Muguruma, N;
Sannomiya, K;
Mitsui, Y;
Takaoka, T;
Kitamura, S;
Miyamoto, H;
Okahisa, T;
Fujimori, T;
Imoto, I;
Takayama, T

Publication type:

Article

miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 365, doi. 10.1038/bjc.2014.593

By:

Zhang, Y;
Dai, J;
Deng, H;
Wan, H;
Liu, M;
Wang, J;
Li, S;
Li, X;
Tang, H

Publication type:

Article

Telomere length is a novel predictive biomarker of sensitivity to anti-EGFR therapy in metastatic colorectal cancer.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 313, doi. 10.1038/bjc.2014.561

By:

Augustine, T A;
Baig, M;
Sood, A;
Budagov, T;
Atzmon, G;
Mariadason, J M;
Aparo, S;
Maitra, R;
Goel, S

Publication type:

Article

Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.

Published in:

British Journal of Cancer, 2015, v. 112, n. 2, p. 278, doi. 10.1038/bjc.2014.585

By:

Daw, N C;
Chou, A J;
Jaffe, N;
Rao, B N;
Billups, C A;
Rodriguez-Galindo, C;
Meyers, P A;
Huh, W W

Publication type:

Article